Hybrid Biomimetic Membrane Coated Particles-Mediated Bacterial Ferroptosis for Acute MRSA Pneumonia
Top Cited Papers
- 13 June 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (12) , 11692-11712
Abstract
Acute methicillin resistant Staphylococcus aureus (MRSA) pneumonia is one of the most frequently seen lung infection diseases with high morbidity and mortality. It is urgent to explore an efficient antibacterial strategy owing to the increase of drug resistance, virulence, and pathogenicity of MRSA. It was found that Fe3O4 can induce ferroptosis in MRSA, but its effect was inhibited by glutathione (GSH) to a certain extent, while cinnamaldehyde (CA) can enhance ferroptosis by consuming GSH. As a bacterial quorum sensing (QS) inhibitor, CA can suppress the QS system and further exert its antibacterial and antibiofilm effects. Here, we developed an Fe3O4-based ferroptosis inducer to promote ferroptosis in MRSA, interrupt the QS, destroy biofilm, and thus effectively treat acute MRSA pneumonia. We used sodium alginate (SA) to wrap Fe3O4 and CA to form particles, and then coated the surface with a hybrid biomimetic membrane composed of an erythrocyte membrane and platelet membrane to obtain lung targeted antibacterial particles (mFe-CA). Under ultrasonic (US) stimulation, mFe-CA can efficiently release Fe3O4 and CA, thereby synergically inducing MRSA death with the characteristics of ferroptosis, including mass ROS production, lipid peroxidation, GSH depletion, and respiratory chain suppression. Furthermore, mFe-CA + US can inhibit the QS system, remove biofilms, and reduce strain virulence. In the mouse model of MRSA pneumonia, mFe-CA + US treatment markedly advanced the survival rate of the mice, reduced the bacterial load in the lungs, and alleviated the inflammatory damage, but there was no obvious toxicity. This study proposes an antibacterial substitute to induce ferroptosis of MRSA, which may provide a foreground for overcoming microbial drug resistance and fighting biofilm-associated infections and also provides a target and theoretical basis for clinical treatment of acute MRSA pneumonia.Keywords
Funding Information
- National Key Research and Development Program of China (2022YFA1104900)
- Science and Technology Department of Zhejiang Province (2020C03035)
- National University of Singapore (NUHSRO/2020/133/Startup/08, NUHSRO/2021/034/TRP/09/Nanomedicine)
- National Natural Science Foundation of China (81873465, 81971667, 82070006, 82241046, 82272222)
- Binjiang Institute of Zhejiang University (ZY202205SMKY006, ZY202205SMKY007)
This publication has 60 references indexed in Scilit:
- Synthetic nanoparticles camouflaged with biomimetic erythrocyte membranes for reduced reticuloendothelial system uptakeNanotechnology, 2016
- Amplification of oxidative stress by a dual stimuli-responsive hybrid drug enhances cancer cell deathNature Communications, 2015
- Platelets Are Not Just for ClotsTransfusion Medicine Reviews, 2015
- Ultrasound-Mediated Local Drug and Gene Delivery Using NanocarriersBioMed Research International, 2014
- A biomimetic nanosponge that absorbs pore-forming toxinsNature Nanotechnology, 2013
- Quorum Sensing and Bacterial Social Interactions in BiofilmsSensors, 2012
- QUORUM SENSING: Cell-to-Cell Communication in BacteriaAnnual Review of Cell and Developmental Biology, 2005
- Alveolar Macrophage Activation by MyeloperoxidaseAmerican Journal of Respiratory Cell and Molecular Biology, 2002
- The biofilm matrix – an immobilized but dynamic microbial environmentTrends in Microbiology, 2001
- Biofilm, City of MicrobesJournal of Bacteriology, 2000